Aldesleukin Recruiting Phase 3 Trials for Melanoma In Situ / Melanoma (Skin) Prevention

IndicationsStatusPurposePhase
RecruitingPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT03233828Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2